Donafenib
| CAS号 | 1130115-44-4 | 货号 | BCP34023 |
| 中文名 | Donafenib | ||
| 英文名 | Donafenib | ||
| 中文别名 | |||
| 英文别名 | Sorafenib (D3); CM-4307; CM 4307; CM4307;Bay 43-9006 (D3); | ||
| 分子式 | C21H13D3ClF3N4O3 | 分子量 | 467.85 |
| 生物活性 | Donafenib is an orally available multikinase inhibitor that targets Raf kinase and various receptor tyrosine kinases (RTKs), with potential antineoplastic activity. Upon oral administration, donafenib binds to and blocks the activity of Raf kinase, and inhibits Raf-mediated signal transduction pathways. This inhibits cell proliferation in Raf-expressing tumor cells. In addition, this agent may inhibit unidentified RTKs, and thus may further block tumor cell proliferation in susceptible tumor cells. Raf, a serine/threonine protein kinase, plays a key role in the Raf/mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling pathway. Deregulation of this pathway often results in tumor cell proliferation and survival. | ||
| 信号通路 | Angiogenesis/Protein Tyrosine Kinase Apoptosis Pathway MAPK Pathway | ||
| 靶 点 | Ferroptosis VEGFR FLT3 Raf | ||
结构式
本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。
不同批次的产品详情请咨询我们的客服：
- 全国免费电话：400-099-8200
- 在线客服:
瀚香生物（Biochempartner) 的所有产品和服务仅用于科学研究，禁止用于人体和治疗！